Fabrizio Messina

No ORCID on file · 1 paper in corpus · active 2024

Study types

  • rct 1

Condition tags

  • endometriosis 1
  • chronic_pelvic_pain 1
rct 2024
Efficacy and safety of eliapixant in endometriosis-associated pelvic pain: the randomized, placebo-controlled phase 2b SCHUMANN study
BMC women's health ·doi:10.1186/s12905-024-03188-8

BACKGROUND: The SCHUMANN study evaluated the efficacy and safety of the selective P2 × 3 antagonist eliapixant in patients with endometriosis-associated pelvic pain (EAPP). METHODS: SCHUMANN was a randomized, placebo- and active comparator…